SCHEMBL8715900

SCHEMBL8715900

COc1ccc(/C=C/COC(=N)C(Cl)(Cl)Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A1 P04798 2/20 0.41
PTGS2 P35354 2/20 0.41
CYP1B1 Q16678 2/20 0.41
ALOX12 P18054 1/20 0.41
PTGS1 P23219 1/20 0.41
F3 P13726 1/20 0.41
RELA Q04206 2/20 0.41
TRPA1 O75762 1/20 0.41
AHR P35869 2/20 0.41
THRB P10828 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8715903 1.00 GSK3B (0.43) GSK3BCYP1A2CYP2C19LMNAKDM4E
SCHEMBL8715869 0.83 CACNA1B (0.37) CYP1A2LMNAPTGS2PTGS1AHR
SCHEMBL8715871 0.83 CACNA1B (0.37) CYP1A2LMNAPTGS2PTGS1AHR
SCHEMBL8715251 0.82 PTGS1 (0.39) CYP1A2CYP2C19LMNATP53PTGS2
SCHEMBL8715880 0.82 ALDH1A1 (0.36) CYP1A2CYP2C19LMNAKDM4ECYP3A4
SCHEMBL8715248 0.82 PTGS1 (0.39) CYP1A2CYP2C19LMNATP53PTGS2
SCHEMBL8715879 0.82 ALDH1A1 (0.36) CYP1A2CYP2C19LMNAKDM4ECYP3A4
SCHEMBL8718564 0.81 IDO1 (0.49) KDM4ETP53CYP3A4ALDH1A1PTGER4
SCHEMBL8718561 0.81 IDO1 (0.49) KDM4ETP53CYP3A4ALDH1A1PTGER4
SCHEMBL8718628 0.81 CA12 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0722448-A4 O-ARYL, O-ALKYL, O-ALKENYL AND O-ALKYNYL-MACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY MERCK & CO INC (US) 1998-04-29 EP disclosed
US-5693648-A TREATMENT OF AUTOIMMUNE DISEASES, INFECTIOUS DISEASES, PREVENTING REJECTION OF ORGAN TRANSPLANTS MERCK & CO., INC. (US) 1997-12-02 US disclosed
US-5565560-A TREATING AUTOIMMUNE DISEASES, PREVENTING TRANSPLANT REJECTION MERCK & CO., INC. (US) 1996-10-15 US disclosed
EP-0722448-A1 O-ARYL, O-ALKYL, O-ALKENYL AND O-ALKYNYL-MACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY MERCK & CO. INC. (US) 1996-07-24 EP disclosed
US-5532248-A O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity MERCK CO., INC. (US) 1996-07-02 US disclosed
WO-1995009857-A1 O-ARYL, O-ALKYL, O-ALKENYL AND O-ALKYNYL-MACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY MERCK & CO., INC. (US) 1995-04-13 WO disclosed
US-5250678-A For autoimmune, infectious diseases, organ transplant rejection; skin diseases, antiinflammatory agents MERCK & CO., INC. (US) 1993-10-05 US disclosed
EP-0515071-A2 O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity MERCK & CO. INC. (US) 1992-11-25 EP disclosed